相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。BRAF inhibitor-associated ERK activation drives development of chronic lymphocytic leukemia
Niuscha Yaktapour et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Collision of chronic lymphocytic leukemia/small lymphocytic lymphoma and melanoma
[Anonymous]
BLOOD (2013)
Single-Center Experience With Ipilimumab in an Expanded Access Program for Patients With Pretreated Advanced Melanoma
Sofie Wilgenhof et al.
JOURNAL OF IMMUNOTHERAPY (2013)
Single-Institution Experience With Ipilimumab in Advanced Melanoma Patients in the Compassionate Use Setting Lymphocyte Count After 2 Doses Correlates With Survival
Geoffrey Y. Ku et al.
CANCER (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Review: Anti-CTLA-4 antibody ipilimumab: Case studies of clinical response and immune-related adverse events
Jeffrey Weber
ONCOLOGIST (2007)
分享论文
